Markets:

Overview

News

Currencies

International

Treasuries

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

24.50 -0.46 (-1.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Centessa Pharmaceuticals plc - American Depositary Shares

< Previous 1 2 3 4 Next >

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 09, 2024

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

Via Benzinga

SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday ↗

February 09, 2024

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.

Via Benzinga

Topics Stocks

Where Centessa Pharmaceuticals Stands With Analysts ↗

August 15, 2023

Via Benzinga

Centessa Pharmaceuticals: Q1 Earnings Insights ↗

May 12, 2023

Via Benzinga

Analyst Ratings for Centessa Pharmaceuticals ↗

August 11, 2022

Within the last quarter, Centessa Pharmaceuticals (NASDAQ:CNTA) has observed the following analyst ratings:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 27, 2023

Via Benzinga

IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday ↗

October 26, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 13, 2023

Via Benzinga

Centessa Culls Early-Stage Asset For Inherited Disorder ↗

August 10, 2022

Via Benzinga

BMO Capital Sees Almost 300% Upside On Centessa Stock ↗

June 17, 2022

Via Benzinga

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday ↗

July 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows

June 23, 2023

Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows

Via News Direct

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023 ↗

June 21, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 ↗

June 12, 2023

Via Benzinga

Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday ↗

November 22, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary ↗

September 14, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗

March 17, 2023

Via Benzinga

FDA Grants Orphan Drug Status To Centessa's Hemophilia B Candidate ↗

September 14, 2022

Centessa Pharmaceuticals (NASDAQ: CNTA) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to SerpinPC for the treatment of hemophilia B. A Phase 2a...

Via Benzinga

Morgan Stanley Downgrades Centessa Pharmaceuticals: Here's What You Need To Know ↗

August 12, 2022

Morgan Stanley downgraded its rating of Centessa Pharmaceuticals (NASDAQ:CNTA) to Underweight with a price target of $5.00, changing its price target from $10.00 to $5.00. Shares of Centessa...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗

August 12, 2022

Via Benzinga

Goldman Sachs Maintains Neutral Rating for Centessa Pharmaceuticals: Here's What You Need To Know ↗

August 11, 2022

Goldman Sachs has decided to maintain its Neutral rating of Centessa Pharmaceuticals (NASDAQ:CNTA) and lower its price target from $5.00 to $4.00. Shares of Centessa Pharmaceuticals are trading down...

Via Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Centessa Pharmaceuticals: Q2 Earnings Insights ↗

August 10, 2022

Centessa Pharmaceuticals (NASDAQ:CNTA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 03, 2022

During Friday's trading, 69 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 02, 2022

Via Benzinga

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

53 Stocks Moving In Thursday's Mid-Day Session ↗

June 02, 2022

Gainers

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

Headline News about Centessa Pharmaceuticals plc - American Depositary Shares

Starting at $3.75/week.

Subscribe Today